Motus GI Holdings Inc (NASDAQ:MOTS) Short Interest Update

Share on StockTwits

Motus GI Holdings Inc (NASDAQ:MOTS) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 800,300 shares, an increase of 28.7% from the May 30th total of 621,900 shares. Approximately 5.6% of the shares of the company are sold short. Based on an average daily trading volume, of 137,700 shares, the days-to-cover ratio is presently 5.8 days.

In other Motus GI news, Chairman David P. Hochman purchased 10,000 shares of the company’s stock in a transaction dated Monday, July 1st. The shares were bought at an average price of $3.00 per share, with a total value of $30,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Life Sciences Maste Perceptive purchased 1,000,000 shares of the company’s stock in a transaction dated Thursday, June 27th. The shares were acquired at an average cost of $3.00 per share, for a total transaction of $3,000,000.00. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 2,059,332 shares of company stock valued at $6,179,896. Corporate insiders own 18.14% of the company’s stock.

Several institutional investors have recently bought and sold shares of MOTS. RTW Investments LP increased its holdings in shares of Motus GI by 672.5% in the fourth quarter. RTW Investments LP now owns 459,478 shares of the company’s stock worth $1,429,000 after buying an additional 400,000 shares during the period. Nantahala Capital Management LLC bought a new stake in shares of Motus GI during the 4th quarter valued at $1,555,000. Perceptive Advisors LLC grew its position in shares of Motus GI by 14.2% during the 4th quarter. Perceptive Advisors LLC now owns 3,210,542 shares of the company’s stock valued at $9,984,000 after acquiring an additional 400,000 shares during the period. Maven Securities LTD bought a new stake in shares of Motus GI during the 4th quarter valued at $167,000. Finally, Spark Investment Management LLC grew its position in shares of Motus GI by 73.5% during the 1st quarter. Spark Investment Management LLC now owns 28,900 shares of the company’s stock valued at $112,000 after acquiring an additional 12,245 shares during the period. 35.30% of the stock is owned by hedge funds and other institutional investors.

Shares of Motus GI stock traded down $0.02 on Friday, hitting $3.13. The company had a trading volume of 399,554 shares, compared to its average volume of 256,392. The firm has a market capitalization of $67.57 million, a PE ratio of -2.54 and a beta of 1.61. Motus GI has a 1 year low of $2.34 and a 1 year high of $8.48. The stock’s 50 day simple moving average is $3.41. The company has a debt-to-equity ratio of 0.05, a current ratio of 6.36 and a quick ratio of 6.31.

Motus GI (NASDAQ:MOTS) last issued its quarterly earnings data on Friday, May 10th. The company reported ($0.29) EPS for the quarter, hitting the consensus estimate of ($0.29). As a group, analysts anticipate that Motus GI will post -1.14 EPS for the current year.

A number of research firms have weighed in on MOTS. Piper Jaffray Companies decreased their price target on Motus GI from $8.00 to $6.00 in a research note on Friday, May 10th. Oppenheimer set a $10.00 target price on Motus GI and gave the stock a “buy” rating in a research note on Thursday, March 28th. Zacks Investment Research downgraded GENEL ENERGY PL/ADR from a “buy” rating to a “hold” rating in a research note on Tuesday, May 7th. Finally, ValuEngine downgraded Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Motus GI has a consensus rating of “Buy” and an average target price of $8.60.

Motus GI Company Profile

Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Recommended Story: What is the formula for the cash asset ratio?

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.